Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study

Journal of Trace Elements in Medicine and Biology

Volumn 32, Issue , 2015, Pages 66-72

  Paiva, Ana N ^a   Lima, Josivan G de ^a   Medeiros, Anna C Q de ^a   Figueiredo, Heverton A O ^a   Andrade, Raiana L de ^a   Ururahy, Marcela A G ^a   Rezende, Adriana A ^a   Brandão Neto, José ^a   Almeida, Maria das G ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Chromium picolinate; Dietary supplements; Dyslipidemia; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; CHROMIUM PICOLINATE; FERRITIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; PICOLINIC ACID; PICOLINIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHROMIUM BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THERAPY EFFECT; TREATMENT OUTCOME; CASE CONTROL STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENT; HYPERGLYCEMIA; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PICOLINIC ACIDS;

EID: 84939600497     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2015.05.006     Document Type: Article

References (45)

1. International Diabetes Federation IDF Diabetes Atlas 2013, IDF. 6th ed.
2. Singer G.M., Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol. Ther. 2006, 8:636-643.
3. Landman G.W., Bilo H.J., Houweling S.T., Kleefstra N. Chromium does not belong in the diabetes treatment arsenal: current evidence and future perspectives. World J. Diabetes 2014, 5:160-164.
4. Wang Z.Q., Cefalu W.T. Current concepts about chromium supplementation in type 2 diabetes and insulin resistance. Curr. Diabetes Rep. 2010, 10:145-151.
5. Lewicki S., Zdanowski R., Krzyzowska M., Lewicka A., Debski B., Niemcewicz M., et al. The role of chromium III in the organism and its possible use in diabetes and obesity treatment. Ann. Agric. Environ. Med. 2014, 21:331-335.
6. Vincent J.B. Chromium celebrating 50 years as an essential element?. Dalton Trans. 2010, 39:3787-3794.
7. Gomes M.R., Rogero M.M., Tirapegui J. Considerações sobre cromo, insulina e exercício físico. Rev. Bras. Med. Esporte. 2005, 11:262-266.
8. Anderson R.A. Chromium and insulin resistance. Nutr. Res. Rev. 2003, 16:267-275.
9. Jeejeebhoy K.N., Chu R.C., Marliss E.B., Greenberg G.R., Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am. J. Clin. Nutr. 1977, 30:531-538.
10. Organização Mundial de Saúde (OMS) Cromo. In: Elementos traço na nutrição e saúde humanas 1998, 135-138. OMS, São Paulo: Rocca.
11. Standards of medical care in diabetes-2011, Diabetes Care, 2011, 34 (Suppl 1), S11-61.
12. Armitage P., Berry G. The planning of statistical investigations. Statistical Methods in Medical Research 1987, 179-185. Blackwell, Oxford. 2nd ed.
13. Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Cheng N., Chi J., et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997, 46:1786-1791.
14. World Health Organization Obesity: preventing and managing the global epidemic. Report of a WHO Consulation. WHO Technical Report Series 894 2004, 2:6-15. WHO.
15. IOM Dietary Reference Intakes: Application in Dietary Assesment 2000, National Academic Press, Washington, D.C.
16. C.S. Reinstein, DIETWIN [computer program], Versão Profissional 2011, Porto Alegre (RS), 2011.
17. Pinheiro A.B.V., Lacerda E.M.A., Benzecry E.H., Gomes M.C.S., Costa V.M. Tabela para avaliação de consumo alimentar em medidas caseiras 2000, Editora Atheneu, São Paulo. 4th ed.
18. Tabela Brasileira de Composição de Alimentos/NEPA -UNICAMP. 4th ed. rev. e ampl. Campinas: NEPA -UNICAMP, 2011.
19. United States Department of Agriculture (USDA), U.S. Department of Agriculture, Agricultural Research Service, National Nutrient Database for Standard Reference, Release 21. Nutrient Data Laboratory Home Page, 2008. Disponível em: . http://www.ars.usda.gov/ba/bhnrc/ndl.
20. Institute of Medicine Dietary Reference Intakes: for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc 2001, National Academy Press, Washington, D.C.
21. A. Field, Descobrindo a estatística usando o Spss. 2 ed., Porto Alegre: Artmed, 2009.
22. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
23. Meigs J.B., Nathan D.M., D'Agostino R.B., Wilson P.W. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002, 25:1845-1850.
24. Monami M., Adalsteinsson J.E., Desideri C.M., Ragghianti B., Dicembrini I., Mannucci E. Fasting and post-prandial glucose and diabetic complication, a meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2013, 23:591-598.
25. Standards of medical care in diabetes-2014. Diabetes Care. 2014, 37 (Suppl 1) S14-80.
26. Martin J., Wang Z.Q., Zhang X.H., Wachtel D., Volaufova J., Matthews D.E., et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 2006, 29:1826-1832.
27. Singer G.M., Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol. Ther. 2006, 8(6):636-643.
28. Albarracin C.A., Fuqua B.C., Evans J.L., Goldfine I.D. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab. Res. Rev. 2008, 24:41-51.
29. Sharma S., Agrawal R.P., Choudhary M., Jain S., Goyal S., Agarwal V. Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J. Trace Elem. Med. Biol. 2011, 25:149-153.
30. Racek J., Sindberg C.D., Moesgaard S., Mainz J., Fabry J., Muller L., et al. Effect of chromium-enriched yeast on fasting plasma glucose, glycated haemoglobin and serum lipid levels in patients with type 2 diabetes mellitus treated with insulin. Biol. Trace Elem. Res. 2013, 155:1-4.
31. Lai M.H. Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitus. J. Clin. Biochem. Nutr. 2008, 43:191-198.
32. Broadhurst C.L., Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus-a review. Diabetes Technol. Ther. 2006, 8:677-687.
33. Wiernsperger N., Rapin J. Trace elements in glucometabolic disorders: an update. Diabetol. Metab. Syndr. 2010, 2:1-9.
34. Bahijiri S.M., Mira S.A., Mufti A.M., Ajabnoor M.A. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med. J. 2000, 21:831-837.
35. Krol E., Krejpcio Z., Byks H., Bogdanski P., Pupek-Musialik D. Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biol. Trace Elem. Res. 2011, 143:726-737.
36. Guimarães M.M., Martins Silva Carvalho A.C., Silva M.S. Chromium nicotinate has no effect on insulin sensitivity, glycemic control, and lipid profile in subjects with type 2 diabetes. J. Am. Coll. Nutr. 2013, 32:243-250.
37. Iqbal N., Cardillo S., Volger S., Bloedon L.T., Anderson R.A., Boston R., et al. Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metab. Syndr. Relat. Disord. 2009, 7:143-150.
38. Anderson R.A. Chromium as an essential nutrient for humans. Regul. Toxicol. Pharmacol. 1997, 26:S35-S41.
39. Batchuluun B., Matsumata T., Erdenebileg N., Tsagaantsooj G., Boldbaatar K., Khasag A. Serum ferritin level is higher in poorly controlled patients with Type 2 diabetes and people without diabetes, aged over 55 years. Diabet. Med. 2013, 31:419-424.
40. Dekker L.H., Nicolaou M., van der A.D., Busschers W.B., Brewster L.M., Snijder M.B., et al. Sex differences in the association between serum ferritin and fasting glucose in type 2 diabetes among South Asian Surinamese, African Surinamese, and ethnic Dutch: the population-based SUNSET study. Diabetes Care 2013, 36:965-971.
41. Sun L., Zong G., Pan A., Ye X., Li H., Yu Z., et al. Elevated plasma ferritin is associated with increased incidence of type 2 Diabetes in middle-aged and elderly Chinese adults. J. Nutr. 2013, 143(1):459-465.
42. M. Silva, Participação e homeostase do ferro no diabetes tipo 1 em modelos animais [Thesis], Ouro Preto: Universidade Federal de Ouro Preto, 2011.
43. Lukaski H.C., Williams A.J., Siders, James G.P. Chromium picolinate supplementation in women: effects on body weght, composition, and iron status. Nutrition 2007, 23:187-195.
44. Campbell W.W., Beard J.L., Joseph L.J., Davey S.L., Evans W.J. Chromium picolinate supplementation and resistive training by older men: effects on iron-status and hematologic indexes. Am. J. Clin. Nutr. 1997, 66:944-949.
45. Lukaski H.C., Bolonchuk W.W., Siders W.A., Milne D.B. Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am. J. Clin. Nutr. 1996, 63:954-965.